Nuveen Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$43.4M Buy
519,253
+31,331
+6% +$2.62M 0.01% 711
2024
Q3
$35.7M Sell
487,922
-79,902
-14% -$5.85M 0.01% 838
2024
Q2
$38.9M Sell
567,824
-251,851
-31% -$17.2M 0.01% 746
2024
Q1
$56.7M Sell
819,675
-61,356
-7% -$4.25M 0.02% 588
2023
Q4
$63.1M Buy
881,031
+167,770
+24% +$12M 0.02% 520
2023
Q3
$37.2M Sell
713,261
-246,679
-26% -$12.8M 0.01% 694
2023
Q2
$60.8M Buy
959,940
+171,276
+22% +$10.8M 0.02% 513
2023
Q1
$42.7M Buy
788,664
+52,016
+7% +$2.82M 0.02% 616
2022
Q4
$39M Buy
736,648
+177,924
+32% +$9.42M 0.02% 639
2022
Q3
$26M Sell
558,724
-79,874
-13% -$3.72M 0.01% 853
2022
Q2
$36.5M Sell
638,598
-119,262
-16% -$6.81M 0.01% 686
2022
Q1
$44.4M Buy
757,860
+123,973
+20% +$7.27M 0.01% 691
2021
Q4
$22.2M Sell
633,887
-6,932
-1% -$243K 0.01% 1157
2021
Q3
$23.9M Sell
640,819
-53,939
-8% -$2.01M 0.01% 1150
2021
Q2
$28.4M Sell
694,758
-67,000
-9% -$2.73M 0.01% 1102
2021
Q1
$25.8M Sell
761,758
-16,561
-2% -$562K 0.01% 1131
2020
Q4
$24.8M Sell
778,319
-12,717
-2% -$404K 0.01% 1110
2020
Q3
$20.3M Buy
791,036
+104,018
+15% +$2.67M 0.01% 1054
2020
Q2
$17.6M Buy
687,018
+107,525
+19% +$2.76M 0.01% 1125
2020
Q1
$8.91M Buy
579,493
+236,929
+69% +$3.64M ﹤0.01% 1359
2019
Q4
$11.8M Buy
342,564
+100,953
+42% +$3.46M ﹤0.01% 1493
2019
Q3
$1.81M Sell
241,611
-376,643
-61% -$2.81M ﹤0.01% 2447
2019
Q2
$8.02M Buy
+618,254
New +$8.02M ﹤0.01% 1742
2016
Q3
Sell
-32,726
Closed -$1.27M 1384
2016
Q2
$1.27M Buy
32,726
+13,928
+74% +$541K 0.01% 925
2016
Q1
$523 Buy
18,798
+4,211
+29% +$117 ﹤0.01% 1188
2015
Q4
$785 Sell
14,587
-2,102
-13% -$113 ﹤0.01% 1130
2015
Q3
$668 Buy
+16,689
New +$668 ﹤0.01% 1180